GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Trans-Pacific Strategic Economic Partnership Agreement (TPP); provisions related to intellectual property, market access and public health issues Transatlantic Trade and Investment Partnership (TTIP); provisions related to market access intellectual property, regulatory harmonization and other issuesIndia innovation, IP and market access issues International market access and intellectual property issues Trade Promotion Authority; provisions relations to pharmaceutical IP Canada IP and market access issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| SHIRA KILCOYNE | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| EDYTA WIESNER | — |
| KIMBERLY A WILLIAMS | — |
Defense DEF
H.R. 1960 - National Defense Authorization Act of 2014; provisions related to proposed judiciary amendment
| Lobbyist | Covered position, as disclosed |
|---|---|
| SARAH J WALSH | — |
Taxation/Internal Revenue Code TAX
Tax reform policy issues; issues related to corporate tax reform
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Copyright/Patent/Trademark CPT
H.R. 2582 - PATENT Jobs Act; provisions related to patent user fees H.R. 2766 - STOP Act; provisions related to business method patents H.R. 3309 - Innovation Act; provisions related to patent litigation reform H.R. 3349 - Innovation Protection Act ; provisions related to PTO fee diversionH.R. 3540 - Demand Letter Transparency Act S. 214 - The Preserve Access to Affordable Generics Act; provisions relating to patent settlements S. 504 - Fair and Immediate Release of Generic Drugs Act; provisions related to patent settlements S. 866 - Patent Quality Improvement Act of 2013; Business methods patents provisions Biopharmaceutical innovation policy issues Biologics data protection issues Counterfeit drug issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Health Issues HCR
H.R. 3204 - Drug Quality and Security Act; provisions relating to pharmacy compounding and supply chain H.R. 6584 - Verifying Authority and Legality in Drug Compounding Act; provisions relating to drug compounding H.R. 3742 - Antibiotic Development to Advance Patient Treatment Act S. 957 - Drug Supply Chain Security Act; provisions related to supply chain securityS. 959 - Pharmaceutical Compounding Quality and Accountability Act; provisions related to pharmaceutical compounding S. 1165 - Access to Appropriate Immunizations for Veterans Act of 2013; provisions related to extending VA performance measure to include all federally recommended vaccine S. 610 - Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts H.R. 1248 - Family Health Care Flexibility Act; provisions relating to reimbursement of OTC drugs under flexible spending and health savings accounts H.R. 2725 - Food and Drug Administration Safety Over Sequestration Act of 2013; provisions related to FDA user fees Implementation issues relating to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking FDA special medical use; issues related to limited population antibacterial drug approval pathway FDA accelerated approval policy issues Comparative effectiveness policy issues Biopharmaceutical innovation policy issues Pharmaceutical supply chain security issues 340B policy issues Implementation issues relating to the Physician Payment Sunshine Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Medicare/Medicaid MMM
H.R. 351 - Protecting Seniors' Access to Medicare Act of 2013; provisions related to the Independent Payment Advisory Board H.R. 928 - Medicare Prescription Drug Savings and Choice Act of 2013; provisions related to Medicare Part D H.R. 1024 - Medication Therapy Empowerment Act of 2013; provisions related to Part D issues H.R. 1588 - Medicare Drug Savings Act of 2013; provisions related to Part D issuesH.R. 2810 - Medicare Patient Access and Quality Improvement Act of 2013 S. 117 - Medicare Prescription Drug Price Negotiation Act of 2013; provisions related to Part D issues S. 351 - Protecting Seniors' Access to Medicare Act of 2013; provisions related to the Independent Payment Advisory Board S. 408 - Medicare Prescription Drug Savings and Choice Act of 2013; provisions related to Medicare Part D S. 557 - Medication Therapy Empowerment Act of 2013; provisions related to Part D issues S. 740 - Medicare Drug Savings Act of 2013; provisions related to Part D issues Dual eligibles coordination policy issues Deficit reduction policy issues ; issues related to Medicare Implementation Issues relating to the Physician Payment Sunshine Act Vaccine access and coverage issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Budget/Appropriations BUD
H.R. 2410 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of 2014; provisions relating to FDA regulation and funding, sequestration, drug importation H.J. Res. 59 - FY 14 Continuing Resolution; provisions related to the implementation of the Budget Control Act of 2011: Public Law No. 112-25, funding for the Biomedical Advanced Research and Development Authority (BARDA)S. 1284 - Labor, Health and Human Services, Education and Related Agencies Appropriations Act of 2014; provisions related to ADAP, BARDA and Section 317 FY 14 Omnibus Appriopriations Act; provisions related to FDA and HHS funding
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| JOSEPH MCGOWAN | — |
| STEPHEN SCANGO | — |
| WILLIAM J SCHUYLER | — |
| SARAH J WALSH | — |
| KIMBERLY A WILLIAMS | — |
Tariff (miscellaneous tariff bills) TAR
H.R. 6727; U.S. Job Creation and Manufacturing Competitiveness Act of 2013; provisions related to the temporary duty suspension for preparations, such as tablets or chewing gum, intended to assist smokers to stop smoking (provided for in subheading 2106.90.99)
| Lobbyist | Covered position, as disclosed |
|---|---|
| GARY HEIMBERG | — |
| STEPHEN SCANGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.